QNTM ▼ -0.6% - Quantum BioPharma Ltd.
$QNTM - Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
06-OCT-2026 06:00 AM ET
Share this post
More filings for $QNTM
QNTM ▼ -2.2% - Quantum BioPharma Ltd.Nov 13, 2026QNTM ▲ +0.5% - Quantum BioPharma Ltd.Nov 11, 2026QNTM ▼ -7.7% - Quantum BioPharma Ltd.Nov 5, 2026QNTM - Quantum BioPharma Ltd. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026QNTM ▲ +1.6% - Quantum BioPharma Ltd.Sep 17, 2026QNTM ▲ +1.7% - Quantum BioPharma Ltd.Sep 15, 2026
View full $QNTM filing history →💬 Comments
Loading comments…
Leave a comment